Abstract | INTRODUCTION:
Liposomes are well-known as drug carriers, and are now critical components of two of six types of adjuvants present in licensed vaccines. The liposomal vaccine adjuvant field has long been dynamic and innovative, and research in this area is further examined as new commercial products appear in parallel with new vaccines. In an arena where successful products exist the potential for new types of vaccines with liposomal adjuvants, and alternative liposomal adjuvants that could emerge for new types of vaccines, are discussed. AREAS COVERED: EXPERT OPINION:
|
Authors | Carl R Alving, Zoltan Beck, Gary R Matyas, Mangala Rao |
Journal | Expert opinion on drug delivery
(Expert Opin Drug Deliv)
Vol. 13
Issue 6
Pg. 807-16
(Jun 2016)
ISSN: 1744-7593 [Electronic] England |
PMID | 26866300
(Publication Type: Journal Article, Review)
|
Chemical References |
- Adjuvants, Immunologic
- Drug Carriers
- Liposomes
- Vaccines
|
Topics |
- Adjuvants, Immunologic
(administration & dosage)
- Animals
- Drug Carriers
- Humans
- Liposomes
- Vaccination
- Vaccines
(administration & dosage)
|